UNSPSC 51123704: Bisaramil

This classification denotes an antiarrhythmic agent with the molecular formula C17H23ClN2O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) FVT2ESG270, chemically known as syn-3-ethyl-7-methyl-3,7-diazabicyclo(3.3.1)non-9-yl p-chlorobenzoate but more generally known as bisaramil, which bears US NIH Compound Identifier 3033742. Bisaramil most often comes in base and hydrochloride forms. European Medicines Agency schedules Bisaramil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05848MIG.

UNSPSC 51123704 Bisaramil, a Commodity code, covers advanced life support and emergency medications that state and local governments procure for emergency medical services, hospital systems, and public health programs. State and local buyers under this code include cities operating emergency medical services and fire rescue operations, state health agencies managing pharmacy benefit programs, and multi-state cooperative purchasing alliances coordinating pharmaceutical procurement across member jurisdictions. The work involves supplying specific medications in standardized vial and injection formats — such as epinephrine, labetalol, adenosine, and diltiazem — with strict expiration-date requirements, often nine months or longer from acceptance, and rapid delivery windows of ten calendar days or less. Vendors must comply with FDA regulations, Good Manufacturing Practices, OSHA Hazard Communication Standards, and Drug Supply Chain Security Act requirements, and maintain comprehensive product liability and network security insurance. Contracts frequently include one-year initial terms with renewal options and performance-penalty provisions for late reporting or missed compliance deadlines.

Recent activity shows solicitations posted in Florida, Texas, and Minnesota through early 2026. The City of Tampa Purchasing Department issued IFB 26P00188 in April 2026, closing April 8, 2026, to supply four medication line items valued at $40,000 for Tampa Fire Rescue, with a Small Local Business Enterprise sheltered-market designation and a 5 percent bid discount cap of $10,000 for SLBE participation. The Texas Health and Human Services Commission posted RFI HHS0017013 in early April 2026 to gather vendor capabilities for a direct-to-manufacturer prescription program aimed at improving cost management and fulfillment efficiency outside traditional pharmacy benefit manager arrangements. The Minnesota Department of Administration, administering the Multistate Cooperative Purchasing Alliance (MMCAP), issued RFP S1070000015802 in January 2026 with a March 26, 2026 response deadline for generic multi-source pharmaceuticals and OTC products to be distributed across participating state and local facilities in Minnesota and Oregon, with awards effective July 1, 2026 and contract terms of two years with optional extensions through June 30, 2028.